Write A 350-Word Outline Including Your Introduction And The

Write A 350 Word Outline Including Your Introduction And Three Referen

Write a 350-word outline including your introduction and three reference resources to be used. The outline should be detailed to reflect your position in the paper.

Your written assignments must follow APA guidelines. Be sure to support your work with specific citations from the week’s Learning Resources and additional scholarly sources as appropriate.

Refer to the Pocket Guide to APA Style to ensure in-text citations and reference list are correct.

In 1972 marijuana was placed in Schedule 1 of the Controlled Substances Act as such the US government considered it to have not accepted medical use in treatment. Currently 14 states of the 50 states have enacted protections to citizens using marijuana for medical purpose.

In this assignment, you will consider federal legislation on this important issue. The issue before Congress is whether to continue the federal prosecution of medical marijuana patients and their providers in accordance with the federal Controlled Substance Act or to permit the use of marijuana when recommended by a physician.

Your paper should do the following: State your position. Your position should take that is opposite to your personal views. Discuss the context of this legislation - name the expected demanders and suppliers as outlined in Health Policy Making in the United States by Beaufort B. Longest 5th Edition. Describe the expected interest groups and their specific arguments. Describe the expected interplay between demanders and suppliers, interest groups, and analyze the public policy environment. State your strategic policy to enhance or diffuse results of public policy environment.

Paper For Above instruction

The legislative debate over federal marijuana laws is complex, involving multiple stakeholders, evolving public opinion, and changing state legislations. For this paper, I will argue against the continuation of federal prosecution of medical marijuana users and providers, emphasizing the importance of aligning federal policy with emerging state laws and public health evidence. This position, although contrary to my personal beliefs, allows for a nuanced understanding of the policy dynamics and stakeholder interests involved.

The historical context begins with the 1972 classification of marijuana as a Schedule I substance under the Controlled Substances Act. This designation implied that marijuana lacked accepted medical use and carried a high potential for abuse, thus restricting its legal availability federally. However, over the decades, numerous states—currently 14—have enacted laws permitting medical marijuana use, creating a patchwork of legal standards across the country. The federal stance remains conservative, but increasing state-level legalization poses significant legal and policy dilemmas.

The demanders in this context include patients with qualifying medical conditions seeking relief through marijuana, healthcare providers who recommend its use, and advocacy groups lobbying for reform. Suppliers are primarily licensed growers and dispensaries operating within state frameworks. According to Longest (2019), these demanders are motivated by medical necessity and the potential for improved health outcomes, whereas suppliers seek economic opportunity within legal boundaries.

Interest groups are divided: advocates argue for medical freedom and patient rights, citing evidence of therapeutic benefits, while opposition groups emphasize risks related to addiction, societal harm, and undermining federal drug laws. The debate is further complicated by federal agencies’ stance and the potential use of law enforcement to enforce federal law against state-compliant entities.

The interplay between demanders and suppliers influences the policy environment. State-level legalization creates a tension between federal authority and local autonomy. Interest groups influence public opinion and legislative agendas, either pushing for reform or restrictive policies. Analyzing this environment reveals a shifting landscape where federal policies may need to adapt to local realities. Strategically, policies could focus on establishing federal standards that recognize medical marijuana’s legitimacy, thereby reducing legal conflicts and promoting public health priorities.

References

  • Longest, B. B. (2019). Health Policy Making in the United States (5th ed.). Health Administration Press.
  • National Institute on Drug Abuse (2020). Is marijuana safe and effective? Retrieved from https://www.drugabuse.gov/publications/research-reports/marijuana/marijuana-safe-effective
  • ProCon.org (2021). Medical Marijuana Policy in the U.S. Retrieved from https://medicalmarijuana.procon.org
  • Hall, W., & Weier, M. (2015). Assessing the public health impacts of legalizing recreational cannabis use in the United States. Clinical Pharmacology & Therapeutics, 97(6), 607-615.
  • Substance Abuse and Mental Health Services Administration (SAMHSA). (2022). Results from the 2021 National Survey on Drug Use and Health. Retrieved from https://samhsa.gov/data
  • United States Congress. (2022). The federal approach to medical marijuana: Policy analysis and recommendations. Congressional Research Service.
  • American Medical Association. (2019). Policy on marijuana as medicine. AMA Policy Database.
  • Mazzoni, S., et al. (2018). State legalization of recreational marijuana and public health outcomes. American Journal of Public Health, 108(8), 1024-1029.
  • Bachhuber, M. A., et al. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Internal Medicine, 174(10), 1668-1673.
  • Reuter, P., & Caulkins, J. P. (2019). The impact of marijuana legalization on public health. Annual Review of Public Health, 40, 383-396.

Related Assignments